Home >
SciPis
Title | Recruiting | SciPi | Results | ||
---|---|---|---|---|---|
351 |
Peer Review of Exposure Models - Determining Best Practices |
||||
350 |
Genotoxicity Data Review |
||||
348 |
Critical Review of Key Studies on Perfluoroalkyl Substances (PFAS)Scoring studies based on their strengths and limitations |
||||
347 |
Peer Review - PM2.5 Mortality StudyPeer review of a new manuscript - estimates of mortality worldwide resulting from exposures to PM2.5 |
||||
345 |
Achieving Carbon NeutralityPeer review of report outlining options for achieving carbon neutrality |
||||
312 |
Recommendations for Assessing Exposures from Infant FormulasEstablishing best practices from available data sets |
||||
311 |
Standing Panel - Petroleum FacilitiesExperts in the toxicology, epidemiology, exposure and risk assessment associated with residents living near petroleum facilities |
||||
276 |
Exposure Reconstruction and Dose-Response Assessment for Inhalation Exposures to Hexavalent ChromiumScience Guidance and Peer Review Panel |
||||
275 |
Toxicity Data Review for a Fungicide Metabolite |
||||
274 |
Peer Review of OEL - 8602 |
||||
273 |
Peer Review of OEL - 335 |
||||
272 |
Expanded Services for SciPinion Experts |
||||
269 |
Peer Review of OEL |
||||
192 |
Repro/Developmental Effects and EU Classification |
||||
191 |
Tumor Board - EGFR Mutation of NSCLCTumor Board - EGFR Mutation of NSCLC |
||||
153 |
Science Advisory Panels: State of the SciencePlease enter access code "PR2019" in the search by code box (upper right corner of the screen) to participate |
||||
145 |
Peer review of the genotoxicity, toxicokinetics, and carcinogenicity of a pesticide |
||||
137 |
Mechanistic evaluation of nicotine as a lung cancer hazardPeer review |
||||
136 |
IFIC Review ExampleAppel, 2005: Diet and Cardiovascular Health |
||||
130 |
EGFR Activation by Oxidative Stress Leading to Mucus HypersecretionPeer Review of Adverse Outcome Pathway (AOP) |
||||
128 |
Academy of Toxicological Sciences - Global Climate Change |
||||
127 |
Key Characteristics of Carcinogens: Refining Approaches to Systematic Evaluations of Mechanistic DataToxForum Session 1/29/18 |
||||
123 |
Peptide Oxidation Leading to HypertensionPeer Review of Adverse Outcome Pathway (AOP) |
||||
121 |
Peptide Oxidation Leading to Hypertension - Review DraftPeer Review of Adverse Outcome Pathway (AOP) |
||||
120 |
Precision MedicineSurvey amongst University Medical Center physicians regarding opinions on precision medicine. |
||||
109 |
Safety Assessment Peer Review, Panel 2Senior level scientists needed for mixed panels of experts (industry, regulatory agency, academic) |
||||
105 |
RASS Webinar: Crowdsourcing Scientific Perspectives with SciPinionHexavalent Chromium as a Case Study, April 12, 2017 |
||||
104 |
Safety Assessment Peer ReviewSenior level scientists needed for mixed panels of experts (industry, regulatory agency, academic) |
||||
99 |
Rodent Respiratory Tract Tumor MOA Experts WantedRecruiting rodent respiratory tract tumor mode of action (MOA) experts |
||||
98 |
Rodent Kidney Tumor MOA Experts WantedRecruiting rodent kidney tumor mode of action (MOA) experts |
||||
97 |
Rodent Liver Tumor MOA Experts WantedRecruiting rodent liver tumor mode of action (MOA) experts |
||||
96 |
Human Relevance of Rodent Liver Tumors - PostersSciPis for Posters @ ToxForum Workshop |
||||
94 |
Human Relevance of Rodent Liver TumorsThe Toxicology Forum October 24-26 |
||||
93 |
ISES 2016 - Exposure Based Testing |
||||
92 |
Pharmacokinetics Experts WantedPaid Peer Review Opportunity #92 $7,000 for ~40-56 hrs OPEN - ACCEPTING VOLUNTEERS |
||||
89 |
OEESC - 2016SciPi for session at OEESC 2016 Conference |
||||
88 |
PBPK/PD Model Peer ReviewPaid Peer Review Opportunity #88 $2,800 for ~16 hrs |
||||
87 |
Red Meat and IARCThis is an example SciPi on the IARC decision on red/processed meat |
||||
84 |
ProSafe Delphi Forum - final roundIs risk management on pace with innovation for uses of nanomaterials? Follow up questions from the forum so far. |
||||
76 |
Trichloroethylene Exposure and the Development of Fetal Cardiac Malformations:What Do the Data Tell Us About Inhalation Exposures Resulting from Vapor Intrusion and Potential Health Risks to Pregnant Women? |
||||
75 |
Diethanolamine-Induced Mouse Liver TumorsMode of Action Evaluation: Abstract #2478/SOT Poster #P604; Annual Meeting 2016 |
||||
74 |
Ethylene Oxide Cancer Risk Assessment |
||||
69 |
In Vivo Toxicologists, Systems Biologists, and Bioinformatics Scientists Wanted: Panel IIPaid Peer Review Opportunity #69 $7,000 for ~56 hrs OPEN - ACCEPTING VOLUNTEERS |
||||
68 |
Toxicologists, Systems Biologists, Cell Biologists, and Bioinformatics Scientists WantedPaid Peer Review Opportunity #68 $7,000 for ~56 hrs |
||||
67 |
In Vivo Toxicologists, Systems Biologists, and Bioinformatics Scientists Wanted: Panel IPaid Peer Review Opportunity #67 $7,000 for ~56 hrs CLOSED |
||||
65 |
Veterinary Histopathologist WantedPaid Peer Review Opportunity #65 $7000 for ~56 hrs |
||||
64 |
ProSafe Delphi PollIs risk management on pace with innovation for nanomaterial uses? |
||||
62 |
Red Meat and IARCThis is an example SciPi on the IARC decision on red/processed meat |
||||
55 |
ISES 2015 - Spot Biomonitoring SamplesUse of Spot Biomonitoring Samples in Environmental Epidemiology |
||||
40 |
Peer ReviewHistopathology Data for Phillips et al. (2015) |
||||
36 |
Precision MedicineSurvey amongst University Medical Center physicians regarding opinions on precision medicine. |
||||
28 |
SOT 2015: Mode of action for tetrachloroethylene and 1,2,3-trichlororopropaneWhat is your confidence in the MOA? |
||||
25 |
Use of 'Secret Science'Should EPA rely on 'Secret Science' to support rule making? |
||||
24 |
SRA 2014: Experiment in Audience Participation: Case Study Using the Mode of Action for tetrachloroethylene-induced liver tumorsWhat is your confidence in the MOA? |
||||
21 |
Endocrine DisruptersWhat are the risks from low level environmental exposures? |
||||
19 |
Genetically Modified Organisms (GMOs)What are the potential risks? |
||||
18 |
Recreational Marijuana UseWhat are the risks? |
||||
17 |
Addressing risks from exogenous vs endogenous DNA adductsIs the assumption of low-dose linearity appropriate? |
||||
14 |
SRA 2014: Hydraulic Fracturing (HF)Regulation, Policy, and Community Issues |